Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bodisen Biotech Hosted Institutional Investors in Yangling, Management to Conduct Investor Meetings in New York.


NEW YORK New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 -- Bodisen Biotech, Inc., (AMEX AMEX

See: American Stock Exchange
:BBC BBC
 in full British Broadcasting Corp.

Publicly financed broadcasting system in Britain. A private company at its founding in 1922, it was replaced by a public corporation under royal charter in 1927.
, London AIM:BODI BODI Business Objects Data Integrator
BODI Business of Diving Institute
, website: www.bodisen.com) the first China-based environmentally friendly bio fertilizer company listed on a US stock exchange, and dually listed in London, today announced that the Bodisen management team, led by Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  Karen Qiong Wang, hosted visits by institutional investors at the company's Yangling headquarters in China on May 18, 2006. The visit was joined by the company's board members and legal counsel from the US. The visitors toured Bodisen's facilities as well as conducted due diligence meetings Due Diligence Meeting

The process of careful investigation by an underwriter to ensure that all material information pertinent to a security issue has been disclosed to prospective investors.
 with management. The Governor of Shaanxi Province also met with members of the delegation.

Bodisen's management will be in New York during the week of May 22, 2006 to meet with other institutional investors. The company's Chairman and CEO Karen Qiong Wang and President Bo Chen will provide an overview of the company's business and operations and its financial results. Bodisen has reported record earnings for the first quarter of 2006 and has reaffirmed 2006 earnings guidance.

A copy of the company's updated investor presentation will be available on the company's website at www.bodisen.com starting on May 22, 2006.

Institutional investors may contact The Piacente Group, Bodisen's U.S. investor relations Investor relations

The process by which the corporation communicates with its investors.
 counsel, at 212-481-2050 regarding the company's meeting schedules in New York.

About Bodisen Biotech, Inc.

A Delaware company, Bodisen is headquartered in the city of Yang Ling, Shaanxi Province, China's agricultural hub. The Bodisen brand is a highly recognized fertilizer brand in China. Its environmentally friendly "green" products support the mandate of the Chinese government to increase crop yields for the purpose of decreasing China's dependency on food imports. Utilizing proprietary agricultural technologies, Bodisen sells over 60 packaged products, broken down into four product categories: Organic Compound Fertilizer; Organic Liquid Fertilizer; Pesticides & Insecticides, and agricultural raw materials. Bodisen's organic fertilizers can be absorbed by plants within 48 hours and enrich soil conditions. These products address grains, vegetables, and fruit crops and have been proven to increase crop yields by 10% to 35% while being environmentally friendly. Among China's population of 1.3 billion, approximately 900 million are farmers whose incomes depend on their crop yields. With approximately 600 (and growing) nationwide distribution centers, Bodisen has experienced rapid growth in its existing business.

Safe Harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 Statement

This press release may contain forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. These statements are based on the current expectations or beliefs of Bodisen Biotech, Inc. management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 19, 2006
Words:443
Previous Article:Atlas Copco Inaugurates New Factory in China.
Next Article:Bausch & Lomb Further Extends Consent Solicitation Deadline with Respect to Tender Offers and Consent Solicitations for 7.125% Debentures Due 2028.
Topics:



Related Articles
STYLEADVISOR SUBSCRIBERS RECEIVE TIMELY ACCESS TO DATA.
Bodisen Biotech Retains The Piacente Group as U.S. Investor Relations Counsel.
Forbes Magazine Ranks Bodisen Biotech Among the Top 20 Growth Companies in China.
Bodisen Biotech Completes Dual Listing of Shares on the London Stock Exchange AIM, Raised GBP 12 Million (US$21.36 million) in Strategic Financing...
Bodisen Biotech Launches New Product, Expands into Agricultural Raw Materials Market, Bodisen Sees Strong Customer Demand; Bodisen Builds Capacity to...
Two Investment Brokerage Firms Update Equity Research Coverage for Bodisen Biotech, Inc.
Bodisen Biotech Signs $2.4 Million in New Contracts.
Chicago Board Options Exchange Lists Options of Bodisen Biotech, Inc.
Bodisen Biotech Inc. Issues Statement Regarding Recent Events.
Bodisen Biotech Joins Russell Microcap Index.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles